Q4 Results: Dr. Reddy’s’ Numbers Beat Estimates On  Higher Sales In Emerging Markets
Dr. Reddy’s Laboratories Ltd. Omeprazole capsules are arranged for a photograph in Mumbai, India. (Photographer: Adeel Halim/Bloomberg)

Q4 Results: Dr. Reddy’s’ Numbers Beat Estimates On Higher Sales In Emerging Markets

Bookmark
Dr. Reddy’s Laboratories Ltd.’s quarterly profit beat estimates due to higher sales in emerging markets, including India.Profit jumped 44 percent year-on-year to Rs 434 crore in the March quarter, ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.